Log in to save to my catalogue

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agent...

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agent...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fcf2d01d0e734c67a1d1c66e299f7f7d

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C

About this item

Full title

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C

Publisher

Basel: MDPI AG

Journal title

Pharmaceutics, 2021-10, Vol.13 (10), p.1683

Language

English

Formats

Publication information

Publisher

Basel: MDPI AG

More information

Scope and Contents

Contents

This study aims to develop a new self-report tool (HCV-AD) measuring adherence factors, intentional or unintentional, during Hepatitis C Virus (HCV) treatment with direct-acting antivirals (DAA) aiming to achieve high efficacy, otherwise resulting in drug resistance and treatment failure. Two phases were conducted: in the first phase, items were ge...

Alternative Titles

Full title

Development and Validation of a Questionnaire to Measure Medication Adherence to Direct-Acting Agents in Patients with Hepatitis C

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fcf2d01d0e734c67a1d1c66e299f7f7d

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fcf2d01d0e734c67a1d1c66e299f7f7d

Other Identifiers

ISSN

1999-4923

E-ISSN

1999-4923

DOI

10.3390/pharmaceutics13101683

How to access this item